A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine Donald G. Lamprecht, PharmD, Anne M.

Slides:

Advertisements

Similar presentations

2002 Air Medical Transport Industry Awards Air Medical Journal Volume 22, Issue 2, Pages (March 2003) DOI: /S X(03) Copyright.

Advertisements

Patient request for pharmacist counseling and satisfaction: Automated prescription delivery system versus regular pick-up counter Jan D. Hirsch, PhD Journal.

Lipid abnormalities in foreign-born and US-born patients in a medical group Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,

Donald Gardenier, Amelia Schreibman, Rosemary Henrich

A clinician's guide to statin drug-drug interactions

Should Antibiotics Be Given Routinely to Prevent Joint Implant Infections in Patients Undergoing Dental Procedures? Donald Gardenier The Journal for.

Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels† Eli.

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data Steve E. Humphries, PhD, FRCP, Jackie Cooper,

An assessment by the Statin Cognitive Safety Task Force: 2014 update

An assessment by the Statin Muscle Safety Task Force: 2014 update

An assessment by the Statin Liver Safety Task Force: 2014 update

Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: A double-blinded, randomized, placebo controlled.

Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients Evan Stein, MD, Harold Bays, MD, Michael Koren,

A review of PCSK9 inhibition and its effects beyond LDL receptors

Pharmacist-to-prescriber intervention to close therapeutic gaps for statin use in patients with diabetes: A randomized controlled trial Hannah M. Renner,

Donald Gardenier, Amelia Schreibman, Rosemary Henrich

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,

Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C- III levels in patients from the MARINE and ANCHOR studies Christie.

Predictors of first-year statin medication discontinuation: A cohort study Heli Halava, MD, Risto Huupponen, MD, PhD, Jaana Pentti, BSc, Mika Kivimäki,

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1- year growth data Steve E. Humphries, PhD, FRCP, Jackie Cooper,

Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study)

Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

Practice Notes from the AAAI

Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized.

Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,

Charles J. Glueck, MD, Alan Brown, MD, Anne C. Goldberg, MD, James M

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary Terry A. Jacobson, MD, Matthew.

Temporal Trends in Lipid Screening for Familial Hypercholesterolemia in Youth Catherine J. McNeal, MD, PhD, Justin Zachariah, MD, MPH, Laurel Copeland,

Paul D. Thompson, MD, John Rubino, MD, Matthew J. Janik, MD, Diane E

Short Total Sleep Time and Elevated Central Apnea Index are Significant Predictors of Coronary Artery Disease* Tina Constantin, MD, Jeremy R. Anthony,

Donald Gardenier The Journal for Nurse Practitioners

Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National.

An assessment by the Statin Intolerance Panel: 2014 update

Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States Sudhir K. Unni, PhD, MBA, Ruben G.W.

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a)

Extended-Release Niacin/Laropiprant Lowers Serum Phosphorus Concentrations in Patients with Type 2 Diabetes and Mild Hyperphosphatemia Andrew G. Bostom,

Nutritional Considerations for Dialysis Vegetarian Patients, Part Two

Should Nurses' Undergraduate Training Be in the Humanities?

Epidemiology of opportunistic infections in AIDS patients

Do Nurse Practitioners Need Postgraduate Training?

Severe Constipation Clinical Gastroenterology and Hepatology

Todd Michael Tartavoulle, CNS-BC The Journal for Nurse Practitioners

Practice Notes from the AAAAI

The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study Michael Davidson, MD, Michael Stevenson, RPh, PhD, Andrew Hsieh,

Efficacy and Safety of Sebelipase Alfa in Children and Adults with Lysosomal Acid Lipase Deficiency: Results of a Phase 3 Trial† Sandra Rojas-Caro, Barbara.

News & Notes Journal of Allergy and Clinical Immunology

Support Your Specialty

Sokunthea Peou, PharmD, Brittany Milliard-Hasting, MD, Sachin A

Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials Allan D. Sniderman, MD, James A. Sloand,

Table of contents The Journal for Nurse Practitioners

Christopher S. Penet, Brian H. Annex, MD, Kelly T. Gregory, R

Reviewer Acknowledgment

News & Notes Journal of Allergy and Clinical Immunology

Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review Ilse K. Luirink, MD, Jim.

Table of contents The Journal for Nurse Practitioners

Journal of Investigative Dermatology

Higher long-term adherence to statins in rural patients at high atherosclerotic risk Matthew R. Peverelle, MD, BBiomed, Arul Baradi, MBChB, Sarang Paleri,

Are Male Nurses Treated Differently?

Can Low-Radiation Coronary Computed Tomography Angiography Improve Upon Clinical Risk Assessment in Patients with Familial Hypercholesterolemia?* Anna.

Practice Notes from the AAAI

Should Supervision be Required for Early-Career Nurse Practitioners?

Prediction of Cardiovascular Disease Events by Lipoprotein(a) According to LDL-C in Older High Risk Adults Nathan D. Wong, PhD, Shravanthi R. Gandra,

Footnotes1 Journal of Allergy and Clinical Immunology

Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol—The role of LDL-apheresis Mary P. McGowan, MD, FNLA

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary Terry A. Jacobson, MD, Matthew.

Volume 50, Issue 2, Pages iii-iv (April 2019)

News & Notes Journal of Allergy and Clinical Immunology

Is Being the Most Trusted Profession a Good Thing?

Should Patients Order Their Own Genomic Testing?

Presentation transcript:

A Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins with Cyclosporine Donald G. Lamprecht, PharmD, Anne M. Denham, PharmD, Leslie K. Ruppe, PharmD, Sheila L. Stadler, PharmD, Brittany A. Todd, PharmD Journal of Clinical Lipidology Volume 9, Issue 3, Pages 436-437 (May 2015) DOI: 10.1016/j.jacl.2015.03.046 Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions

Journal of Clinical Lipidology 2015 9, 436-437DOI: (10. 1016/j. jacl Copyright © 2015 Terms and Conditions